Peptide Database

A synthetic 11-amino acid peptide that mimics the tissue-protective actions of erythropoietin without its erythropoietic effects. Highly effective for neuropathic pain and nerve repair.

A 15-amino acid peptide fragment derived from a protective protein found in gastric juice. Remarkably effective at accelerating healing of tendons, ligaments, muscles, and gut tissue.

A tetrapeptide (Ala-Glu-Asp-Leu) from the Khavinson bioregulator series specifically targeting bronchial and lung tissue. Studied for COPD, chronic bronchitis, and smoking-related lung damage. Normalizes bronchial epithelium proliferation and reduces respiratory inflammation.

A tetrapeptide cardiac bioregulator from the Khavinson series targeting myocardial tissue. Normalizes myocardial cell function, reduces cardiac oxidative stress, and provides cardioprotection against ischemia and aging-related cardiac decline. Studied for heart failure, cardiomyopathy, and post-infarction recovery.

A cartilage and bone-targeting peptide bioregulator from the Khavinson series. Studied for arthritis, osteochondrosis, fracture recovery, and joint aging. Stimulates chondrocyte proliferation and collagen synthesis in cartilage tissue, supporting structural repair and maintenance of joint integrity.

A peptide bioregulator targeting bronchial mucosa from the Khavinson series. Distinct from Bronchogen (which targets bronchial parenchyma), Chonluten specifically targets the mucous membrane lining of the bronchi. Studied for COPD, chronic mucus hypersecretion, and respiratory tract aging.

A 33-amino acid intestinal peptide secreted from L-cells of the gut that promotes intestinal mucosal growth, improves gut barrier function, and reduces inflammation. The FDA-approved analog Teduglutide (Gattex) is used for short bowel syndrome. GLP-2 research focuses on gut permeability, IBS/IBD, Crohn's disease, and gut-brain axis effects.

A naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminus of alpha-MSH. Anti-inflammatory, antimicrobial, and gut-protective without causing skin pigmentation. Highly studied for IBD, Crohn's disease, skin conditions, and wound healing.

An 8-amino acid synthetic peptide designed to regulate tight junctions between intestinal epithelial cells. Directly targets intestinal permeability (leaky gut) and is the only compound in clinical trials specifically for tight junction regulation in celiac disease.

A liver-targeting tetrapeptide bioregulator. Normalizes hepatocyte function, reduces liver fibrosis, improves bile acid metabolism, and protects against hepatotoxicity. Studied for NAFLD, alcohol-related liver damage, hepatitis recovery, and liver aging.

A synthetic version of Thymosin Beta-4, a naturally occurring protein present in nearly all human cells. Promotes cellular healing, anti-inflammation, and tissue regeneration throughout the entire body.

A synthetic 4-amino acid fragment (Ac-SDKP) derived from the N-terminus of Thymosin Beta-4. This specific fragment is responsible for many of TB-500's anti-inflammatory, stem cell mobilization, and cardiac healing properties, in a more targeted and stable form.

A 28-amino acid neuropeptide naturally found throughout the nervous system and gastrointestinal tract. Acts as a potent vasodilator, immune modulator, and anti-inflammatory agent. Used in the Shoemaker CIRS/mold illness protocol and studied for pulmonary hypertension.